Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)

Small Molecules Studied

  • Page 1 of 2
  • 1 to 25 of 34 Small Molecules
HMS LINCS ID Name Alternative Names LINCS ID Structure Image PubChem CID
10006-1 AZD7762 LSM-1006 67077825
10020-1 Dasatinib
BMS-354825; Sprycel
LSM-1020 3062316
10032-1 Saracatinib
AZD0530
LSM-1032 10302451
10047-1 Pictilisib
Pictrelisib; GDC-0941; RG-7321
LSM-1047 17755052
10071-1 Palbociclib
PD0332991
LSM-1071 5330286
10080-1 Torin2 LSM-1080 51358113
10102-4 Taxol
Paclitaxel
LSM-1102 441276
10131-1 Tivantinib
ARQ197
LSM-1131 11494412
10142-1 Trametinib
GSK-1120212; GSK1120212; GSK1120212B; JTP-74057
LSM-1143 11707110
10144-3 Olaparib
AZD2281; KU-0059436
LSM-1145 23725625
10147-1 Buparlisib
BKM120; NVP-BKM120
LSM-1148 16654980
10161-1 Luminespib
NVP-AUY922
LSM-1162 53401173
10171-1 TGX221 LSM-1172 9907093
10179-1 ABT-737 LSM-1180 11228183
10194-1 Cabozantinib
XL-184; BMS-907351
LSM-1195 25102847
10205-1 INK-128
MLN0128
LSM-1206 45375953
10282-2 Vorinostat
suberoylanilide hydroxamic acid (SAHA); Zolinza
LSM-3828 5311
10248-3 Doxorubicin
Adriamycin
LSM-4062 31703
10233-1 Alpelisib
BYL719
LSM-4256 56649450
10235-1 Everolimus
RAD001
LSM-4258 53398658
10245-4 Cisplatin
CDDP; cis-Diaminodichloroplatinum; Cisplatinum; Lederplatin; Briplatin; Cismaplat
LSM-4268
10018-1 Neratinib
HKI-272
LSM-42778 53398697
10445-1 Taselisib
GDC-0032; RG-7604
LSM-45140 51001932
10278-2 Topotecan
Hycamtin
LSM-5662 60700
10287-2 Dinaciclib
SCH727965
LSM-6306 46926350
  • Page 1 of 2
  • 1 to 25 of 34 Small Molecules